CN Stock MarketDetailed Quotes

002275 Guilin Sanjin Pharmaceutical

Watchlist
  • 14.78
  • +0.02+0.14%
Trading Nov 28 10:34 CST
8.68BMarket Cap21.27P/E (TTM)

Guilin Sanjin Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-3.49%1.57B
-10.53%1.07B
-32.59%482.59M
10.81%2.17B
13.40%1.63B
19.96%1.19B
38.51%715.93M
12.55%1.96B
14.60%1.44B
13.13%995.47M
Operating revenue
-3.49%1.57B
-10.53%1.07B
-32.59%482.59M
10.81%2.17B
13.40%1.63B
19.96%1.19B
38.51%715.93M
12.55%1.96B
14.60%1.44B
13.13%995.47M
Other operating revenue
----
-63.85%2.44M
----
-30.63%3.66M
----
107.05%6.75M
----
94.55%5.27M
----
68.30%3.26M
Total operating cost
-2.05%1.14B
-4.48%733.37M
-29.15%354.63M
4.21%1.69B
9.56%1.16B
19.27%767.8M
36.02%500.56M
17.14%1.62B
10.61%1.06B
6.30%643.74M
Operating cost
-8.12%396.2M
-15.42%269.99M
-30.92%124.31M
3.10%586.4M
8.62%431.23M
15.09%319.24M
39.30%179.95M
27.22%568.78M
8.17%397M
2.83%277.39M
Operating tax surcharges
-0.59%23.66M
-5.12%17.62M
-43.48%4.9M
3.46%37.33M
-0.73%23.8M
2.64%18.57M
39.27%8.67M
10.00%36.09M
12.29%23.97M
11.51%18.1M
Operating expense
9.53%501.43M
6.46%291.44M
-14.75%155.07M
33.35%717.86M
30.62%457.81M
59.87%273.74M
58.89%181.9M
-4.71%538.34M
13.14%350.49M
8.34%171.23M
Administration expense
-28.25%109.37M
-17.88%76.55M
-24.91%38.77M
-26.07%202.81M
-10.30%152.44M
-14.00%93.22M
19.82%51.63M
75.49%274.33M
55.64%169.95M
50.78%108.4M
Financial expense
21.20%-4.69M
-30.46%-1.27M
-128.52%-1.5M
2.27%-14.41M
-2.91%-5.95M
89.65%-971.89K
5.18%5.24M
29.31%-14.74M
63.89%-5.78M
36.56%-9.39M
-Interest expense (Financial expense)
-69.43%8.2M
-5.66%5.4M
-71.99%3.05M
-19.17%16.36M
97.00%26.81M
-76.48%5.72M
194.69%10.9M
11.12%20.24M
-5.84%13.61M
--24.32M
-Interest Income (Financial expense)
80.45%-6.74M
-13.83%-8.9M
-4.19%-5.49M
19.86%-31.18M
-39.05%-34.48M
77.34%-7.82M
-125.51%-5.26M
0.91%-38.91M
19.69%-24.8M
---34.51M
Research and development
9.04%114.85M
23.49%79.03M
-54.78%33.09M
-27.17%158.06M
-17.31%105.33M
-17.96%64M
4.43%73.16M
7.20%217.04M
-24.94%127.38M
-25.33%78.01M
Credit Impairment Loss
4.69%-5.17M
-78.06%-10.04M
-85.52%-13.52M
99.77%-9.05K
-6,343.84%-5.42M
23.50%-5.64M
-203.50%-7.29M
-206.15%-3.91M
102.87%86.86K
-155.92%-7.37M
Asset Impairment Loss
40.63%-3.07M
----
----
-189.21%-16.17M
-439.92%-5.17M
-96.37%55.19K
-94.82%78.75K
68.85%-5.59M
--1.52M
--1.52M
Other net revenue
186.90%31.02M
169.65%20.21M
-3.01%-724.97K
-67.52%34.71M
-53.36%10.81M
8.21%7.49M
-116.60%-703.8K
51.43%106.89M
-65.20%23.19M
-63.61%6.93M
Fair value change income
289.40%1.58M
186.69%753.54K
----
631.94%1.19M
8.58%-836.6K
5.01%-869.26K
----
-90.79%162.92K
31.65%-915.14K
31.65%-915.14K
Invest income
147.18%862.81K
167.50%351.93K
-565.53%-387.46K
15.04%1.99M
4.52%-1.83M
64.01%-521.4K
109.84%83.23K
225.28%1.73M
2.42%-1.92M
69.67%-1.45M
-Including: Investment income associates
----
----
----
-37,211.81%-1.14M
----
----
----
-28.04%3.07K
----
----
Asset deal income
275.82%4.14M
267.96%4.31M
405.58%4.55M
-94.67%1.67M
-2,325.76%-2.35M
-333,029.09%-2.56M
---1.49M
106.58%31.24M
-99.32%105.7K
-100.00%-769.7
Other revenue
23.68%32.68M
45.82%24.84M
9.05%8.63M
-44.70%46.04M
8.71%26.42M
12.49%17.03M
14.97%7.91M
15.01%83.25M
-57.67%24.3M
26.26%15.14M
Operating profit
-2.71%464.99M
-18.12%355.25M
-40.73%127.23M
16.00%518.26M
19.74%477.92M
20.97%433.86M
40.20%214.66M
4.14%446.78M
10.49%399.14M
22.27%358.66M
Add:Non operating Income
-23.91%466.51K
-43.23%237.29K
-83.78%39.96K
-25.89%561.46K
-36.68%613.12K
-33.01%417.99K
-58.03%246.39K
-14.84%757.61K
47.78%968.22K
-26.20%624K
Less:Non operating expense
-51.19%465.55K
12.86%360.84K
-35.41%74.95K
-60.22%540.68K
-76.92%953.75K
49.10%319.71K
-3.18%116.03K
56.74%1.36M
873.46%4.13M
74.74%214.43K
Total profit
-2.64%464.99M
-18.16%355.13M
-40.78%127.19M
16.16%518.28M
20.61%477.58M
20.85%433.96M
39.86%214.79M
3.99%446.18M
9.55%395.98M
22.11%359.07M
Less:Income tax cost
0.53%81.11M
-0.48%54.16M
-40.36%27.18M
-16.86%96.99M
12.70%80.68M
-3.10%54.42M
35.91%45.57M
36.69%116.65M
4.41%71.59M
19.82%56.16M
Net profit
-3.28%383.88M
-20.70%300.97M
-40.90%100.02M
27.85%421.3M
22.35%396.89M
25.30%379.54M
40.96%169.23M
-4.13%329.53M
10.75%324.38M
22.54%302.92M
Net profit from continuing operation
-3.28%383.88M
-20.70%300.97M
-40.90%100.02M
27.85%421.3M
22.35%396.89M
25.30%379.54M
40.96%169.23M
-4.13%329.53M
10.75%324.38M
22.54%302.92M
Net profit of parent company owners
-3.28%383.88M
-20.70%300.97M
-40.90%100.02M
27.85%421.3M
22.35%396.89M
25.30%379.54M
40.96%169.23M
-4.13%329.53M
10.75%324.38M
22.54%302.92M
Earning per share
Basic earning per share
-4.41%0.65
-21.54%0.51
-41.38%0.17
28.57%0.72
23.64%0.68
22.64%0.65
38.10%0.29
-6.67%0.56
8.03%0.55
23.26%0.53
Diluted earning per share
-4.41%0.65
-21.54%0.51
-41.38%0.17
28.57%0.72
23.64%0.68
22.64%0.65
38.10%0.29
-6.67%0.56
8.03%0.55
23.26%0.53
Other composite income
47.40%-13.33M
-27.42%-11.84M
-377.78%-9.27M
-260.78%-36.85M
-294.63%-25.34M
-253.84%-9.3M
-292.03%-1.94M
953.45%22.92M
802.28%13.02M
618.03%6.04M
Other composite income of parent company owners
47.40%-13.33M
-27.42%-11.84M
-377.78%-9.27M
-260.78%-36.85M
-294.63%-25.34M
-253.84%-9.3M
-292.03%-1.94M
953.45%22.92M
802.28%13.02M
618.03%6.04M
Total composite income
-0.27%370.55M
-21.91%289.13M
-45.75%90.75M
9.08%384.45M
10.12%371.55M
19.84%370.25M
39.92%167.28M
3.35%352.45M
15.93%337.4M
25.58%308.96M
Total composite income of parent company owners
-0.27%370.55M
-21.91%289.13M
-45.75%90.75M
9.08%384.45M
10.12%371.55M
19.84%370.25M
39.92%167.28M
3.35%352.45M
15.93%337.4M
25.58%308.96M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -3.49%1.57B-10.53%1.07B-32.59%482.59M10.81%2.17B13.40%1.63B19.96%1.19B38.51%715.93M12.55%1.96B14.60%1.44B13.13%995.47M
Operating revenue -3.49%1.57B-10.53%1.07B-32.59%482.59M10.81%2.17B13.40%1.63B19.96%1.19B38.51%715.93M12.55%1.96B14.60%1.44B13.13%995.47M
Other operating revenue -----63.85%2.44M-----30.63%3.66M----107.05%6.75M----94.55%5.27M----68.30%3.26M
Total operating cost -2.05%1.14B-4.48%733.37M-29.15%354.63M4.21%1.69B9.56%1.16B19.27%767.8M36.02%500.56M17.14%1.62B10.61%1.06B6.30%643.74M
Operating cost -8.12%396.2M-15.42%269.99M-30.92%124.31M3.10%586.4M8.62%431.23M15.09%319.24M39.30%179.95M27.22%568.78M8.17%397M2.83%277.39M
Operating tax surcharges -0.59%23.66M-5.12%17.62M-43.48%4.9M3.46%37.33M-0.73%23.8M2.64%18.57M39.27%8.67M10.00%36.09M12.29%23.97M11.51%18.1M
Operating expense 9.53%501.43M6.46%291.44M-14.75%155.07M33.35%717.86M30.62%457.81M59.87%273.74M58.89%181.9M-4.71%538.34M13.14%350.49M8.34%171.23M
Administration expense -28.25%109.37M-17.88%76.55M-24.91%38.77M-26.07%202.81M-10.30%152.44M-14.00%93.22M19.82%51.63M75.49%274.33M55.64%169.95M50.78%108.4M
Financial expense 21.20%-4.69M-30.46%-1.27M-128.52%-1.5M2.27%-14.41M-2.91%-5.95M89.65%-971.89K5.18%5.24M29.31%-14.74M63.89%-5.78M36.56%-9.39M
-Interest expense (Financial expense) -69.43%8.2M-5.66%5.4M-71.99%3.05M-19.17%16.36M97.00%26.81M-76.48%5.72M194.69%10.9M11.12%20.24M-5.84%13.61M--24.32M
-Interest Income (Financial expense) 80.45%-6.74M-13.83%-8.9M-4.19%-5.49M19.86%-31.18M-39.05%-34.48M77.34%-7.82M-125.51%-5.26M0.91%-38.91M19.69%-24.8M---34.51M
Research and development 9.04%114.85M23.49%79.03M-54.78%33.09M-27.17%158.06M-17.31%105.33M-17.96%64M4.43%73.16M7.20%217.04M-24.94%127.38M-25.33%78.01M
Credit Impairment Loss 4.69%-5.17M-78.06%-10.04M-85.52%-13.52M99.77%-9.05K-6,343.84%-5.42M23.50%-5.64M-203.50%-7.29M-206.15%-3.91M102.87%86.86K-155.92%-7.37M
Asset Impairment Loss 40.63%-3.07M---------189.21%-16.17M-439.92%-5.17M-96.37%55.19K-94.82%78.75K68.85%-5.59M--1.52M--1.52M
Other net revenue 186.90%31.02M169.65%20.21M-3.01%-724.97K-67.52%34.71M-53.36%10.81M8.21%7.49M-116.60%-703.8K51.43%106.89M-65.20%23.19M-63.61%6.93M
Fair value change income 289.40%1.58M186.69%753.54K----631.94%1.19M8.58%-836.6K5.01%-869.26K-----90.79%162.92K31.65%-915.14K31.65%-915.14K
Invest income 147.18%862.81K167.50%351.93K-565.53%-387.46K15.04%1.99M4.52%-1.83M64.01%-521.4K109.84%83.23K225.28%1.73M2.42%-1.92M69.67%-1.45M
-Including: Investment income associates -------------37,211.81%-1.14M-------------28.04%3.07K--------
Asset deal income 275.82%4.14M267.96%4.31M405.58%4.55M-94.67%1.67M-2,325.76%-2.35M-333,029.09%-2.56M---1.49M106.58%31.24M-99.32%105.7K-100.00%-769.7
Other revenue 23.68%32.68M45.82%24.84M9.05%8.63M-44.70%46.04M8.71%26.42M12.49%17.03M14.97%7.91M15.01%83.25M-57.67%24.3M26.26%15.14M
Operating profit -2.71%464.99M-18.12%355.25M-40.73%127.23M16.00%518.26M19.74%477.92M20.97%433.86M40.20%214.66M4.14%446.78M10.49%399.14M22.27%358.66M
Add:Non operating Income -23.91%466.51K-43.23%237.29K-83.78%39.96K-25.89%561.46K-36.68%613.12K-33.01%417.99K-58.03%246.39K-14.84%757.61K47.78%968.22K-26.20%624K
Less:Non operating expense -51.19%465.55K12.86%360.84K-35.41%74.95K-60.22%540.68K-76.92%953.75K49.10%319.71K-3.18%116.03K56.74%1.36M873.46%4.13M74.74%214.43K
Total profit -2.64%464.99M-18.16%355.13M-40.78%127.19M16.16%518.28M20.61%477.58M20.85%433.96M39.86%214.79M3.99%446.18M9.55%395.98M22.11%359.07M
Less:Income tax cost 0.53%81.11M-0.48%54.16M-40.36%27.18M-16.86%96.99M12.70%80.68M-3.10%54.42M35.91%45.57M36.69%116.65M4.41%71.59M19.82%56.16M
Net profit -3.28%383.88M-20.70%300.97M-40.90%100.02M27.85%421.3M22.35%396.89M25.30%379.54M40.96%169.23M-4.13%329.53M10.75%324.38M22.54%302.92M
Net profit from continuing operation -3.28%383.88M-20.70%300.97M-40.90%100.02M27.85%421.3M22.35%396.89M25.30%379.54M40.96%169.23M-4.13%329.53M10.75%324.38M22.54%302.92M
Net profit of parent company owners -3.28%383.88M-20.70%300.97M-40.90%100.02M27.85%421.3M22.35%396.89M25.30%379.54M40.96%169.23M-4.13%329.53M10.75%324.38M22.54%302.92M
Earning per share
Basic earning per share -4.41%0.65-21.54%0.51-41.38%0.1728.57%0.7223.64%0.6822.64%0.6538.10%0.29-6.67%0.568.03%0.5523.26%0.53
Diluted earning per share -4.41%0.65-21.54%0.51-41.38%0.1728.57%0.7223.64%0.6822.64%0.6538.10%0.29-6.67%0.568.03%0.5523.26%0.53
Other composite income 47.40%-13.33M-27.42%-11.84M-377.78%-9.27M-260.78%-36.85M-294.63%-25.34M-253.84%-9.3M-292.03%-1.94M953.45%22.92M802.28%13.02M618.03%6.04M
Other composite income of parent company owners 47.40%-13.33M-27.42%-11.84M-377.78%-9.27M-260.78%-36.85M-294.63%-25.34M-253.84%-9.3M-292.03%-1.94M953.45%22.92M802.28%13.02M618.03%6.04M
Total composite income -0.27%370.55M-21.91%289.13M-45.75%90.75M9.08%384.45M10.12%371.55M19.84%370.25M39.92%167.28M3.35%352.45M15.93%337.4M25.58%308.96M
Total composite income of parent company owners -0.27%370.55M-21.91%289.13M-45.75%90.75M9.08%384.45M10.12%371.55M19.84%370.25M39.92%167.28M3.35%352.45M15.93%337.4M25.58%308.96M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data